GigOptix to Acquire RF and Semiconductor Solutions Provider, Endwave

Provider of ultra-performance electro-optic and electronic parts, GigOptix has inked a definitive merger deal to buy Endwave, a supplier of semiconductor components and ultra frequency RF solutions for electronic instruments and wireless mobile backhaul communications.

The new company, GigOptix, will provide high frequency, ultra-speed wireless and optical communication solutions. The merger is slated for completion in the Q2 of 2011. The combined entity will simplify the supply chains of both optical and wireless mobile backhaul networks and thus will offer comprehensive ultra-speed solutions to end users.

The new company will provide ultra speed design competencies in both optical and point-to-point radio networks and will offer economical and sophisticated production, testing and assembly at Endwave’s Thailand facility. The merger will also take the integration of electro-optical front-ends to the next level by using Endwave’s MLMS system-on-chip technology and GigOptix’ Thin Film Polymer on Silicon technology, mixed signal technologies and high speed broadband ICs.

The merger will enable the development of microwave photonic transceivers, electro-optical transceivers on a chip and electro-optical systems-on-a-chip, including integrated modulators and drivers for base stations.

The Chairman and Chief Executive Officer at GigOptix, Avi Katz stated that by utilizing Endwave’s production expertise, the combined firm could strengthen Gigoptix’s ultra-speed fiber optic front-end technology to offer advanced solutions for future generation 100 and 400 G electro-optic sub-systems and drivers.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.